First Tracks Biotherapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| – | -0.5% | -25.2% | |
| – | -2.2% | -18.9% | |
| – | +242.2% | +93.5% | |
| – | -1.4% | -19.1% | |
| – | +46.8% | -14.4% | |
| – | +98.6% | -14.3% | |
| – | +8.3% | +8.1% | |
| – | +56.1% | -17.8% | |
| – | -4.5% | -26.6% | |
| – | +0.0% | +0.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.